BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 23649937)

  • 1. Cationic host defence peptides: potential as antiviral therapeutics.
    Gwyer Findlay E; Currie SM; Davidson DJ
    BioDrugs; 2013 Oct; 27(5):479-93. PubMed ID: 23649937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad-Spectrum Antiviral Entry Inhibition by Interfacially Active Peptides.
    Hoffmann AR; Guha S; Wu E; Ghimire J; Wang Y; He J; Garry RF; Wimley WC
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the antiviral activity of cationic antimicrobial peptides.
    Urmi UL; Vijay AK; Kuppusamy R; Islam S; Willcox MDP
    Peptides; 2023 Aug; 166():171024. PubMed ID: 37172781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral potential of cathelicidins.
    Barlow PG; Findlay EG; Currie SM; Davidson DJ
    Future Microbiol; 2014; 9(1):55-73. PubMed ID: 24328381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral Activities of Human Host Defense Peptides.
    Brice DC; Diamond G
    Curr Med Chem; 2020; 27(9):1420-1443. PubMed ID: 31385762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral Peptides (AVPs) of Marine Origin as Propitious Therapeutic Drug Candidates for the Treatment of Human Viruses.
    Sukmarini L
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35565968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral mechanisms of human defensins.
    Wilson SS; Wiens ME; Smith JG
    J Mol Biol; 2013 Dec; 425(24):4965-80. PubMed ID: 24095897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptides as model molecules for the development of novel antiviral agents in aquaculture.
    Falco A; Ortega-Villaizan M; Chico V; Brocal I; Perez L; Coll JM; Estepa A
    Mini Rev Med Chem; 2009 Sep; 9(10):1159-64. PubMed ID: 19817709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospects For the Use of Peptides against Respiratory Syncytial Virus].
    Shilovskiy IP; Andreev SM; Kozhikhova KV; Nikolskii AA; Khaitov MR
    Mol Biol (Mosk); 2019; 53(4):541-560. PubMed ID: 31397431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current progress in antiviral strategies.
    Lou Z; Sun Y; Rao Z
    Trends Pharmacol Sci; 2014 Feb; 35(2):86-102. PubMed ID: 24439476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mining the tree of life: Host defense peptides as antiviral therapeutics.
    Shartouny JR; Jacob J
    Semin Cell Dev Biol; 2019 Apr; 88():147-155. PubMed ID: 29524585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulators of innate immunity as novel targets for panviral therapeutics.
    Es-Saad S; Tremblay N; Baril M; Lamarre D
    Curr Opin Virol; 2012 Oct; 2(5):622-8. PubMed ID: 23017246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate defences against viraemia.
    Singh IP; Baron S
    Rev Med Virol; 2000; 10(6):395-403. PubMed ID: 11114078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promising role of defensins peptides as therapeutics to combat against viral infection.
    Solanki SS; Singh P; Kashyap P; Sansi MS; Ali SA
    Microb Pathog; 2021 Jun; 155():104930. PubMed ID: 33933603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human Antimicrobial Peptides as Therapeutics for Viral Infections.
    Ahmed A; Siman-Tov G; Hall G; Bhalla N; Narayanan A
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31374901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.
    Sample CJ; Hudak KE; Barefoot BE; Koci MD; Wanyonyi MS; Abraham S; Staats HF; Ramsburg EA
    Peptides; 2013 Oct; 48():96-105. PubMed ID: 23891650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silver nanoparticles as potential antiviral agents.
    Galdiero S; Falanga A; Vitiello M; Cantisani M; Marra V; Galdiero M
    Molecules; 2011 Oct; 16(10):8894-918. PubMed ID: 22024958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defensins in innate antiviral immunity.
    Klotman ME; Chang TL
    Nat Rev Immunol; 2006 Jun; 6(6):447-56. PubMed ID: 16724099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defensins in Viral Infection and Pathogenesis.
    Holly MK; Diaz K; Smith JG
    Annu Rev Virol; 2017 Sep; 4(1):369-391. PubMed ID: 28715972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.
    Findlay F; Proudfoot L; Stevens C; Barlow PG
    Pathog Glob Health; 2016; 110(4-5):137-47. PubMed ID: 27315342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.